Macrophage Activation Syndrome secondary to Systemic Juvenile Idiopathic Arthritis: A Case Report.
juvenile arthritis; macrophage activation syndrome; steroids.
Journal
JNMA; journal of the Nepal Medical Association
ISSN: 1815-672X
Titre abrégé: JNMA J Nepal Med Assoc
Pays: Nepal
ID NLM: 0045233
Informations de publication
Date de publication:
15 Nov 2021
15 Nov 2021
Historique:
received:
11
08
2021
accepted:
17
11
2021
entrez:
24
2
2022
pubmed:
25
2
2022
medline:
26
2
2022
Statut:
epublish
Résumé
Macrophage activation syndrome is a rare but a life threatening condition commonly associated with Systemic Juvenile Idiopathic Arthritis. Its clinical presentation includes fever, hepatosplenomegaly, hypertriglyceridemia, hypofibrinogenemia, hyperferritinemia and impaired liver enzymes. The symptoms are alarming yet non-specific and often lead to a delayed diagnosis. A 12 year male presented with a history of intermittent fever and was started on antibiotics but failed to respond after several days of hospital stay. After a series of investigations to rule out multiple diagnoses he was diagnosed as a case of Macrophage Activation Syndrome secondary to Systemic onset Juvenile Arthritis and was treated with steroids.
Identifiants
pubmed: 35199753
doi: 10.31729/jnma.7019
pmc: PMC9124332
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1166-1169Références
Kathmandu Univ Med J (KUMJ). 2009 Oct-Dec;7(28):411-3
pubmed: 20502084
Indian J Med Sci. 2010 Jul;64(7):333-6
pubmed: 22918076
J Pediatr. 1996 Nov;129(5):630-2
pubmed: 8917224
Rev Bras Reumatol. 2015 Jan-Feb;55(1):79-82
pubmed: 25575650
Arch Dis Child. 2001 Nov;85(5):421-6
pubmed: 11668110
Clin Pediatr (Phila). 2016 Oct;55(11):1001-4
pubmed: 27562237
Open Access Rheumatol. 2018 Aug 31;10:117-128
pubmed: 30214327
Semin Oncol. 1991 Feb;18(1):29-33
pubmed: 1992521